Defective & Dangerous Products

There is talk of a multibillion-dollar settlement to end the 18,000 lawsuits surrounding the Roundup-cancer connection.

Motley Rice’s achievement last week is the epitome of a “never back down” approach that should inspire us all. After nearly 20 years, the firm reached a $305 million settlement in litigation that found that Sherwin-Williams, NL Industries, and ConAgra Grocery Products Company created a…

Journalist Carey Gillian’s 17-year career of covering Monsanto, combined with the Roundup cancer litigation, has brought to light the trust and transparency issues we often see with major corporations.

In case you aren’t already aware, let me be the first to tell you that Fidelma Fitzpatrick, Esq. is a plaintiffs’ superhero. In addition to her legal work at Motley Rice and her involvement in Women En Mass (an annual gathering of the top female…

The FDA is updating its requirements to ensure new products “either account for advances in technology or demonstrate that they meet more modern safety and performance criteria.”

The popular heart drug valsartan may have been contaminated with carcinogen NDMA for as long as four years before anyone discovered the problem.

Transvaginal mesh litigation ranks as one of the largest mass tort cases in U.S. history. Trial lawyers have taken mesh manufacturers to task after 100,000 women suffered injuries from having these defective mesh products surgically implanted to repair pelvic organ prolapse. Last week, a long-overdue…

A move by the U.S. Supreme Court is a big win for plaintiffs who say several companies created a “public nuisance” by concealing serious lead paint hazards.

Our team at Milestone is cheering for our friend and Women En Mass founder Aimee Wagstaff, who serves as co-lead counsel of the national Monsanto Roundup litigation. On July 10, The Honorable Vince Chhabria ruled that the plaintiffs in the case offered reliable scientific evidence…